Pfizer PFE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 73.5%-0.8pp | 74.3%+0.9pp | 73.4%+1.3pp | 72.1%-0.2pp | 72.3%+0.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.1× | 1.2×-0.1× | 1.3×+0.1× | 1.2×-0.1× | 1.3×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.7×-0.1× | 0.8×+0.1× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Per Share | ||||||
| Book value per share | $15.72+3.9% | $15.14-6.8% | $16.24+4.5% | $15.54-1.7% | $15.82+2.2% | |
| Valuation | ||||||
| Market capitalization | $159.73B+12.8% | $141.57B-2.3% | $144.87B+4.8% | $138.21B-3.8% | $143.71B-4.4% | |
| Price / sales | 2.5×+0.3× | 2.3×0.0× | 2.3×+0.1× | 2.2×-0.1× | 2.3×-0.1× | |
| Price / book | 1.8×+0.1× | 1.6×+0.1× | 1.6×0.0× | 1.6×0.0× | 1.6×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Pfizer's ratios come from?
- Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
